1. Home >
  2. M&A >
  3. >
  4. United States >
  5. Virginia >
  6. KKR Invests In Spirox

Investment Summary

KKR Invests In Spirox

On March 15, 2016, private equity firm KKR invested in medical products company Spirox

Investment Highlights
  • This is KKR’s 5th transaction in the Medical Products sector.
  • This is KKR’s 83rd transaction in the United States.
  • This is KKR’s 4th transaction in Virginia.
Investment Fate
  • Spirox was sold to a publicly-traded strategic buyer in 2017 for 25M USD.

Investment Summary
Date 2016-03-15
Target Spirox
Sector Medical Products
Investor(s) KKR
Deal Type Venture

Target

Spirox

Arlington, Virginia, United States
Spirox, Inc. is a medical device company that is focused on developing minimally invasive technologies that improve the quality of life for patients with nasal obstruction. Spirox is based in Arlington, Virginia.

Search 205,905 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

KKR

New York, New York, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1976
PE ASSETS 267.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION
KKR's office in Menlo Park, California.
KKR's office in Menlo Park, California.

KKR is a global investment firm founded by Jerome Kohlberg, Henry Kravis, and George Roberts. The Firm is separated into several business segments including private markets, public markets, capital markets, and other principal activities. KKR's private equity practice invests in management buyouts, take privates, corporate divestitures, industry consolidations, and partnerships with family-owned companies. KKR will invest in a broad range of industries and companies and will consider businesses throughout North America, Europe, Asia, and Australia/New Zealand. Sectors of interest include chemicals, consumer products, energy and natural resources, financial services, healthcare, industrial, media/communications, retail, and technology. In addition to its traditional principal investment activity business, KKR also invests in infrastructure assets. KKR was formed in 1976 and is based in New York, New York.

DEAL STATS #
Overall 204 of 489
Sector (Medical Products) 5 of 9
Type (Venture) 15 of 35
State (Virginia) 4 of 5
Country (United States) 83 of 210
Year (2016) 10 of 26
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-03-03 Van Geloven

Tilburg, Netherlands

Van Geloven is a producer of frozen snacks and appetizers in the Benelux market. The company produces various ragouts products (such as croquettes and bitterballs), satay, nasi and bami products (ethnic Indonesian fried rice, respectively, noodle dish) and minced-meat rolls (frikadellen, hamburgers). Van Geloven was formed in 1960 and is based in Tilburg, Netherlands.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-03-17 Hensoldt

Taufkirchen, Germany

Hensoldt is a provider of sensors for security and surveillance missions. The company is a global player in such areas as missile warning systems and submarine periscopes. Moreover, Hensoldt is very active in the market for radar systems, optronics and electronic protection systems. Hensoldt was founded in 2020 and is based in Taufkirchen, Germany.

Buy €1.1B
Mergr

Product

Company

Legal